Kurt Azarbarzin

All filings by Kurt Azarbarzin on record concern TELA Bio, Inc., in the capacity of board member. We count 10 filings; the first trade dates from 8 November 2019 and the latest from 28 May 2025.

Every open-market trade on record is a purchase: 2 purchases worth €1.0M, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants.

On 30 May 2025 came the latest disclosure, a share grant in TELA Bio, Inc. The last insider purchase was made public on 13 November 2019, 2,553 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.